Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Target 25 installations by YE, up from 14 as of Q2 Conf Call

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Oct 06, 2021 11:51pm

103 Views

Post# 33978480

RE:RE:RE:RE:RE:Target 25 installations by YE, up from 14 as of Q2 Conf Call

Just listened to the Q2 again.

Today - 14 installs with 10 treating patients (USA).
20 new installs over the next 12 months.
Approximately 25 installs in the USA by end of 2021.

-----

Thanks again.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December